Motor neuron disease (MND) Research

Our Research Portfolio

Since our formation in 2017, we have invested over £11 million in a targeted portfolio of MND research to expedite the development of new treatments.

We support innovative projects across all three of the strategic priorities in our research strategy.

Our investments cover lab-based “pre-clinical” research, through to clinical studies to test the most promising treatments in people living with MND.

Strategic Priorities
Sign up to our email newsletters

Follow us on

By using our website you are consenting to our use of cookies in accordance with our privacy policy